Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C: basic and clinical studies.

T Arima1

  • 1Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Japan.

Gastroenterologia Japonica
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

All-optical control of antiferromagnetic domains via an inverse optical magnetoelectric effect.

Nature materials·2026
Same author

Nonreciprocal Directional Dichroism in Magnetoelectric Spin Glass.

Physical review letters·2022
Same author

Particle-size dependent structural transformation of skyrmion lattice.

Nature communications·2020
Same author

Motion tracking of 80-nm-size skyrmions upon directional current injections.

Science advances·2020
Same author

Room-Temperature Low-Field Colossal Magnetoresistance in Double-Perovskite Manganite.

Physical review letters·2019
Same author

Nonreciprocal Refraction of Light in a Magnetoelectric Material.

Physical review letters·2019
Same journal

Abstracts of selected papers presented at the 34th annual meeting of The Japanese Society of Gastroenterology. Utsunomiya, Japan, October 12-14, 1992.

Gastroenterologia Japonica·1993
Same journal

Cisplatin enhances the metastatic potential of human colon carcinoma.

Gastroenterologia Japonica·1993
Same journal

Serum concentration of macrophage colony stimulating factor (M-CSF) in patients with inflammatory bowel disease.

Gastroenterologia Japonica·1993
Same journal

Expression of transforming growth factor-beta receptor type II gene in gastric cancer cell lines.

Gastroenterologia Japonica·1993
Same journal

A case of chronic pancreatitis complicated by massive pericardial and right pleural effusion.

Gastroenterologia Japonica·1993
Same journal

Liver sarcoidosis showing low-density intrahepatic septa on postcontrast computed tomography.

Gastroenterologia Japonica·1993
See all related articles

Hepatitis C virus (HCV) causes most transfusion-associated and community-acquired hepatitis in Japan. Preventing HCV infection through blood screening is crucial to reduce post-transfusion hepatitis incidence.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis C virus (HCV), a flavivirus, is linked to transfusion-associated and community-acquired non-A, non-B hepatitis in Japan.
  • HCV is prevalent in 2% of blood donors and common in high-risk groups like hemophiliacs and hemodialysis patients.
  • HCV infection contributes to hepatitis, liver cirrhosis, and primary liver cancer, and may cause liver disease in alcoholic patients.

Purpose of the Study:

  • To establish the etiological role of HCV in various liver diseases.
  • To explore the potential of recombinant interferon-alpha (IFN-alpha) in treating HCV-related liver disease.
  • To emphasize the importance of preventing HCV infection through blood donor screening.

Main Methods:

  • Epidemiological studies identifying HCV as the cause of NANB hepatitis.

Related Experiment Videos

  • Serological testing for anti-HCV antibodies in patient populations.
  • Review of existing data on HCV's contribution to liver pathology.

    • Main Results:

    • HCV is identified as the primary cause of transfusion-associated and community-acquired NANB hepatitis in Japan.
    • HCV infection is a significant factor in sporadic, acute, and chronic hepatitis, liver cirrhosis, and primary liver cancer.
    • Anti-HCV antibodies were found in 20% of alcoholic patients with liver injury, suggesting HCV's role in these cases.

    Conclusions:

    • HCV is a major etiological agent for liver disease, including hepatitis, cirrhosis, and cancer.
    • Recombinant IFN-alpha shows promise for treating acute and chronic HCV infections, preventing disease progression.
    • Preventing HCV transmission via rigorous blood donor screening is essential to reduce post-transfusion hepatitis.